Page:United States Statutes at Large Volume 115 Part 3.djvu/115

From Wikisource
Jump to navigation Jump to search
This page needs to be proofread.


PUBLIC LAW 107-116—JAN. 10, 2002 115 STAT. 2189 NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES For carrying out section 301 and title IV of the Public Health Service Act with respect to diabetes and digestive and kidney disease, $1,466,833,000. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE For carrying out section 301 and title IV of the Public Health Service Act with respect to neurological disorders and stroke, $1,328,188,000. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (INCLUDING TRANSFER OF FUNDS) For carrying out section 301 and title IV of the Public Health Service Act with respect to allergy and infectious diseases, $2,372,278,000: Provided, That the Director may transfer up to $25,000,000 to International Assistance Programs, "Global Fund to Fight HIV/AIDS, Malaria, and Tuberculosis", to remain available until expended. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES For carrying out section 301 and title IV of the Public Health Service Act with respect to general medical sciences, $1,725,263,000. NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT For carrying out section 301 and title IV of the Public Health Service Act with respect to child health and human development, $1,113,605,000. NATIONAL EYE INSTITUTE For carrying out section 301 and title IV of the Public Health Service Act with respect to eye diseases and visual disorders, $581,366,000. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES For carrying out sections 301 and 311 and title IV of the Public Health Service Act with respect to environmental health sciences, $566,639,000. NATIONAL INSTITUTE ON AGING For carrying out section 301 and title IV of the Public Health • Service Act with respect to aging, $893,443,000. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES For carrying out section 301 and title IV of the Public Health Service Act with respect to arthritis and musculoskeletal and skin diseases, $448,865,000.